G-286. FEATURES OF THE MECHANISM OF  DEVELOPMENT OF PULMONARY HYPERTENSION IN  PATIENTS UNDERGOING HEMODIALYSIS THROUGH  ARTERIOVENOUS ACCESS:

dc.contributor.author	Asal Abduvakhitova1, 2, Durdona Saipova2.
dc.date.accessioned	2026-09-05T13:21:00Z
dc.date.available	2026-09-05T13:21:00Z
dc.date.issued	2025-04-09
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5107
dc.description.abstract	Pulmonary hypertension (PH) is a significant complication in ESRD patients on HD, exacerbated by AV fistulas and involving dysregulation of endothelin-1 (ET-1) and nitric oxide (NO). Aim to evaluate the role of endothelin-1 (ET-1) and nitric oxide (NO) in the development and progression of PH in patients on program hemodialysis and with AV access.	en_US
dc.language.iso	en_US	en_US
dc.publisher	American Journal of Kidney Diseases	en_US
dc.title	G-286. FEATURES OF THE MECHANISM OF DEVELOPMENT OF PULMONARY HYPERTENSION IN PATIENTS UNDERGOING HEMODIALYSIS THROUGH ARTERIOVENOUS ACCESS:	en_US
dc.type	Thesis	en_US